Neutrophils exposed to A. phagocytophilum under shear stress fail to fully activate, polarize, and transmigrate across inflamed endothelium.
Anaplasma phagocytophilum is an obligate intracellular bacterium that has evolved mechanisms to hijack polymorphonuclear neutrophil (PMN) receptors and signaling pathways to bind, infect, and multiply within the host cell. E-selectin is upregulated during inflammation and is a requisite endothelial receptor that supports PMN capture, rolling, and activation of integrin-mediated arrest. Ligands expressed by PMN that mediate binding to endothelium via E-selectin include sialyl Lewis x (sLe(x))-expressing ligands such as P-selectin glycoprotein ligand-1 (PSGL-1) and other glycolipids and glycoproteins. As A. phagocytophilum is capable of binding to sLe(x)-expressing ligands expressed on PMN, we hypothesized that acute bacterial adhesion to PMN would subsequently attenuate PMN recruitment during inflammation. We assessed the dynamics of PMN recruitment and migration under shear flow in the presence of a wild-type strain of A. phagocytophilum and compared it with a strain of bacteria that binds to PMN independent of PSGL-1. Acute bacterial engagement with PMN resulted in transient PMN arrest and minimal PMN polarization. Although the wild-type pathogen also signaled activation of beta2 integrins and elicited a mild intracellular calcium flux, downstream signals including PMN transmigration and phosphorylation of p38 mitogen-activated protein kinase (MAPK) were inhibited. The mutant strain bound less well to PMN and failed to activate beta2 integrins and induce a calcium flux but did result in decreased PMN arrest and polarization that may have been partially mediated by a suppression of p38 MAPK activation. This model suggests that A. phagocytophilum binding to PMN under shear flow during recruitment to inflamed endothelium interferes with normal tethering via E-selectin and navigational signaling of transendothelial migration.
Schaff
U Y
UY
Department of Biomedical Engineering, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Trott
K A
KA
Chase
S
S
Tam
K
K
Johns
J L
JL
Carlyon
J A
JA
Genetos
D C
DC
Walker
N J
NJ
Simon
S I
SI
Borjesson
D L
DL
D041081:Anaplasma phagocytophilum / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D000818:Animals; D001422:Bacterial Adhesion; D018821:CD18 Antigens / Q000378:metabolism; D015820:Cadherins / Q000235:genetics / Q000378:metabolism; D020013:Calcium Signaling; D016764:Cell Polarity; D018920:Coculture Techniques; D042783:Endothelial Cells / Q000276:immunology* / Q000378:metabolism; D018922:HL-60 Cells; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D053583:Interleukin-1beta / Q000378:metabolism; D007700:Kinetics; D007739:L Cells; D036904:Leukocyte Rolling; D008562:Membrane Glycoproteins / Q000378:metabolism; D051379:Mice; D009154:Mutation; D018375:Neutrophil Activation; D009504:Neutrophils / Q000276:immunology / Q000378:metabolism / Q000382:microbiology*; D010766:Phosphorylation; D013314:Stress, Mechanical; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
D018821:CD18 Antigens; D015820:Cadherins; D018836:Inflammation Mediators; D053583:Interleukin-1beta; D008562:Membrane Glycoproteins; C084882:P-selectin ligand protein; D014409:Tumor Necrosis Factor-alpha; D048051:p38 Mitogen-Activated Protein Kinases
J Clin Pathol. 2004 May;57(5):499-503
15113857
Infect Immun. 2004 Aug;72(8):4772-83
15271939
Immunity. 2007 Jun;26(6):773-83
17543554
J Leukoc Biol. 2008 Jan;83(1):99-105
17928459
Cell Microbiol. 2007 Nov;9(11):2644-57
17587335
Infect Immun. 2001 Sep;69(9):5577-88
11500432
Cell Microbiol. 2007 Jul;9(7):1730-7
17346310
J Immunol. 1996 Nov 1;157(9):4133-40
8892649
Infect Immun. 2003 Aug;71(8):4586-94
12874338
J Immunol. 2005 May 15;174(10):6364-72
15879137
Infect Immun. 2005 Dec;73(12):8209-18
16299317
J Immunol. 2001 Oct 1;167(7):4017-25
11564821
Lab Invest. 2002 Mar;82(3):303-11
11896209
Cell Microbiol. 2007 May;9(5):1284-96
17250594
J Clin Invest. 1997 Dec 15;100(12):3014-8
9399947
J Immunol. 2004 Nov 1;173(9):5712-20
15494523
Ann Biomed Eng. 2008 Apr;36(4):632-46
18278555
Infect Immun. 2009 Sep;77(9):4070-80
19564373
J Med Microbiol. 2008 Apr;57(Pt 4):416-423
18349358
J Immunol. 2004 Jun 15;172(12):7780-90
15187162
J Infect Dis. 2001 Jun 15;183(12):1781-6
11372031
Blood. 2003 Apr 15;101(8):3257-64
12480703
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6209-14
8650245
J Gen Microbiol. 1976 Sep;96(1):51-62
789815
Int J Syst Evol Microbiol. 2001 Nov;51(Pt 6):2145-2165
11760958
J Infect Dis. 1997 Sep;176(3):687-92
9291316
Biochem J. 2006 May 15;396(1):89-98
16433632
Curr Opin Cell Biol. 2008 Oct;20(5):525-32
18499427
Microcirculation. 2006 Mar;13(2):99-109
16459323
Infect Immun. 2000 Dec;68(12):6697-703
11083784
Blood. 2007 Apr 1;109(7):2936-43
17132726
Science. 2000 Jun 2;288(5471):1653-6
10834846
Ann Biomed Eng. 2002 Sep;30(8):987-1001
12449760
Infect Immun. 2009 Sep;77(9):4061-9
19451243
Immunity. 2007 Apr;26(4):477-489
17442598
Infect Immun. 2000 Mar;68(3):1125-33
10678916
J Clin Microbiol. 1994 Mar;32(3):589-95
8195363
Infect Immun. 2004 Sep;72(9):5392-401
15322037
J Clin Invest. 1999 Feb;103(3):407-12
9927502
Ann N Y Acad Sci. 2005 Dec;1063:374-82
16481545
Lab Chip. 2007 Apr;7(4):448-56
17389960
Infect Immun. 2004 Jun;72(6):3680-3
15155684
J Immunol. 2000 Apr 15;164(8):4348-58
10754335
Immunity. 2007 Jan;26(1):17-27
17241958
Cell Microbiol. 2006 Dec;8(12):1972-84
16869829
J Infect Dis. 2002 Jul 15;186(2):274-80
12134266
Cell Microbiol. 2008 Sep;10(9):1827-38
18485118